| Cavia porcellus |
Cavia porcellus |
ED50 |
0.0017 |
M l-1 |
10.1016/S0960-894X(01)81166-5 |
| Cavia porcellus |
Cavia porcellus |
ED50 |
0.0036 |
M l-1 |
10.1016/S0960-894X(01)81166-5 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
nan |
None |
10.1016/j.bmcl.2013.04.008 |
| Equus caballus |
Cholinesterase |
IC50 |
nan |
None |
10.1016/j.bmcl.2013.04.008 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Carbonic anhydrase I |
Ki |
nan |
None |
10.1016/j.bmcl.2009.10.036 |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
10.1016/j.bmcl.2009.10.036 |
| Homo sapiens |
Carbonic anhydrase IV |
Ki |
nan |
None |
10.1016/j.bmcl.2009.10.036 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-64.06 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-3.3 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
AUC |
5990.0 |
ng.hr.mL-1 |
None |
| Homo sapiens |
Homo sapiens |
AUC |
6625.0 |
ng.hr.mL-1 |
None |
| Homo sapiens |
Homo sapiens |
AUC |
8189.0 |
ng.hr.mL-1 |
None |
| Homo sapiens |
Homo sapiens |
AUC |
14241.0 |
ng.hr.mL-1 |
None |
| Homo sapiens |
Homo sapiens |
CL |
1.9 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
2.0 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
2.0 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL/F |
119.0 |
mL/min |
None |
| Homo sapiens |
Homo sapiens |
CL/F |
120.0 |
mL/min |
None |
| Homo sapiens |
Homo sapiens |
CL/F |
132.0 |
mL/min |
None |
| Homo sapiens |
Homo sapiens |
CL/F |
151.0 |
mL/min |
None |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.1 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.1 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Cmax |
2218.27 |
nM |
None |
| Homo sapiens |
Homo sapiens |
Cmax |
2914.09 |
nM |
None |
| Homo sapiens |
Homo sapiens |
Cmax |
6021.76 |
nM |
None |
| Homo sapiens |
Homo sapiens |
Cmax |
6497.85 |
nM |
None |
| Homo sapiens |
Homo sapiens |
Fa |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.93 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
1.01 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.92 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
T1/2 |
4.8 |
hr |
None |
| Homo sapiens |
Homo sapiens |
T1/2 |
6.2 |
hr |
None |
| Homo sapiens |
Homo sapiens |
T1/2 |
6.3 |
hr |
None |
| Homo sapiens |
Homo sapiens |
Tmax |
0.6 |
hr |
None |
| Homo sapiens |
Homo sapiens |
Tmax |
2.9 |
hr |
None |
| Homo sapiens |
Homo sapiens |
Tmax |
3.1 |
hr |
None |
| Homo sapiens |
Homo sapiens |
Vdss |
0.7 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
HUVEC |
Activity |
nan |
None |
10.1016/j.ejmech.2022.114331 |
| Homo sapiens |
Hydroxycarboxylic acid receptor 2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase B |
Activity |
nan |
None |
10.1021/jm800656v |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurokinin 1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
Thoracic aorta |
Activity |
nan |
None |
10.1016/j.ejmech.2022.114331 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Activity |
-1.9 |
mmHg |
10.1016/j.bmcl.2009.10.036 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Activity |
28.4 |
mmHg |
10.1016/j.bmcl.2011.04.046 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
EC50 |
10800.0 |
nM |
10.1016/j.bmcl.2009.10.036 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
ED30 |
0.31 |
mg kg-1 |
10.1016/S0960-894X(01)81166-5 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
ED30 |
3.43 |
mg kg-1 |
10.1016/S0960-894X(01)81166-5 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
TIME |
0.5 |
hr |
10.1016/j.bmcl.2011.04.046 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Tmax |
0.5 |
hr |
10.1016/j.bmcl.2009.10.036 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Aorta |
Activity |
77.1 |
% |
10.1016/j.bmc.2013.03.005 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Plasma |
Fu |
1.0 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Rattus norvegicus |
Reduction |
-59.0 |
% |
10.1016/S0960-894X(01)81166-5 |
| Rattus norvegicus |
Rattus norvegicus |
Reduction |
-43.0 |
% |
10.1016/S0960-894X(01)81166-5 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
17.33 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1018 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-2.1 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.08 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.4835 |
None |
10.1101/2020.04.03.023846 |
| None |
ADMET |
CL |
1.7 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
2.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
CL |
2.5 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
6.2 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
CL |
6.9 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
11.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
MRT |
2.3 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
MRT |
5.8 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
1.9 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
4.1 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.5 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
0.6 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
0.7 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.8 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
0.86 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.97 |
mL/min/kg |
10.1002/jps.20373 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
2.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.2 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
0.2 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
0.5 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
EC50 |
9600.0 |
nM |
10.1016/j.bmcl.2009.03.111 |
| None |
NON-PROTEIN TARGET |
EC50 |
100000.0 |
nM |
10.1016/j.bmcl.2009.03.111 |
| None |
NON-PROTEIN TARGET |
Fu |
1.0 |
None |
10.1124/dmd.108.020479 |
| None |
No relevant target |
Activity |
0.412 |
ug ml-1 |
10.1016/j.bmcl.2013.04.008 |
| None |
No relevant target |
Drug metabolism |
0.412 |
ug ml-1 |
10.1016/j.bmc.2013.03.005 |
| None |
No relevant target |
Solubility |
20000.0 |
ug.mL-1 |
10.1016/j.bmcl.2009.10.036 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2022.114331 |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Ratio IC50 |
nan |
None |
10.1016/j.bmcl.2013.04.008 |